In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $6.09 in the last session, up 1.50% from day before closing price of $6.0. In other words, the price has increased by $1.50 from its previous closing price. On the day, 0.69 million shares were traded. TERN stock price reached its highest trading level at $6.18 during the session, while it also had its lowest trading level at $5.99.
Ratios:
We take a closer look at TERN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 30.89 and its Current Ratio is at 30.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 31, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $82.
On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.Mizuho initiated its Buy rating on June 22, 2023, with a $16 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’25 when Kuriakose Emil sold 853 shares for $4.27 per share. The transaction valued at 3,640 led to the insider holds 52,464 shares of the business.
Gengos Andrew bought 10,000 shares of TERN for $39,283 on Jun 27 ’25. The Chief Financial Officer now owns 25,000 shares after completing the transaction at $3.93 per share. On Jun 25 ’25, another insider, Burroughs Amy L., who serves as the Chief Executive Officer of the company, bought 23,314 shares for $3.87 each. As a result, the insider paid 90,230 and bolstered with 47,083 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 531887200 and an Enterprise Value of 198858208.
Stock Price History:
The Beta on a monthly basis for TERN is -0.08, which has changed by -0.30716723 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 53.76%, while the 200-Day Moving Average is calculated to be 30.17%.
Shares Statistics:
According to the various share statistics, TERN traded on average about 896.85K shares per day over the past 3-months and 1048390 shares per day over the past 10 days. A total of 87.30M shares are outstanding, with a floating share count of 66.38M. Insiders hold about 23.99% of the company’s shares, while institutions hold 78.92% stake in the company. Shares short for TERN as of 1751241600 were 6115009 with a Short Ratio of 6.82, compared to 1748563200 on 5438997. Therefore, it implies a Short% of Shares Outstanding of 6115009 and a Short% of Float of 7.000000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 7.0 analysts. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.28 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.1 and -$1.38 for the fiscal current year, implying an average EPS of -$1.19. EPS for the following year is -$1.28, with 7.0 analysts recommending between -$0.76 and -$1.53.
